Lehrstuhl für Innere Medizin IV


close-button

Types of publications

Journal article
Book chapter / Article in edited volumes
Authored book
Translation
Thesis
Edited Volume
Conference contribution
Other publication type
Unpublished / Preprint

Publication year

From
To

Abstract

Journal

Alcohol-mediated renal sympathetic neurolysis for the treatment of hypertension: The Peregrine™ infusion catheter (2020) Bertog S, Sharma A, Mahfoud F, Pathak A, Schmieder R, Sievert K, Papademetriou V, et al. Journal article, Review article Kidney Autotransplantation in a 78-Year-Old Man with Proximal Ureteral Urothelial Carcinoma after Living Donor Nephrectomy (2020) Wacker C, Schiffer M, Richterstetter M, Opgenoorth M, Apel H Journal article Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1–7 randomised controlled trials (2020) Mann J, Hansen T, Idorn T, Leiter LA, Marso SP, Rossing P, Seufert J, et al. Journal article Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation (2020) Marton A, Kaneko T, Kovalik JP, Yasui A, Nishiyama A, Kitada K, Titze J Journal article, Review article Knowledge about immunosuppressant medication and its correlates in a german kidney transplant population – results of a ktx360° substudy (2020) de Boer S, Klewitz F, Bauer-Hohmann M, Schiffer L, Tegtbur U, Pape L, Schiffer M, et al. Journal article Hypertension and kidney disease Bluthochdruck und Nierenerkrankungen (2020) Striepe K, Schmieder R Journal article How to measure retinal microperfusion in patients with arterial hypertension (2020) Szulc U, Dąbrowska E, Pieczyński J, Białkowski P, Narkiewicz K, Schmieder R, Harazny J Journal article, Review article After ten years of follow-up, no difference between supportive care plus immunosuppression and supportive care alone in IgA nephropathy (2020) Rauen T, Wied S, Fitzner C, Eitner F, Sommerer C, Zeier M, Otte B, et al. Journal article Metabolic effects and cardiovascular safety of an oral triple therapy of type 2 diabetes: The metformin, empagliflozin, linagliptin example (2020) Gallwitz B, Schmieder R Journal article Impact of microvascular disease on cardiovascular outcomes in type 2 diabetes: Results from the LEADER and SUSTAIN 6 clinical trials (2020) Verma S, Bain SC, Honoré JB, Mann J, A. Nauck M, E. Pratley R, Rasmussen S, et al. Journal article